Quality of life in patients with acromegaly: a scoping review.
Acromegaly
Psychosocial factors
Quality of life
Scoping review
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
04 Jul 2024
04 Jul 2024
Historique:
received:
04
01
2024
accepted:
06
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
4
7
2024
Statut:
epublish
Résumé
To evaluate the available evidence regarding the quality of life (QoL) in patients with acromegaly, by synthesizing the psychosocial factors of QoL, QoL measures, and complementary interventions targeting QoL. A scoping review was conducted using the PRISMA-ScR guideline. We searched six English databases (PubMed, Embase, CINAHL, Scopus, Web of Science, and the Cochrane Library) from the inception to August 21, 2023. We included observational studies involving psychosocial factors and complementary interventions targeting QoL (concept) in patients with acromegaly (population) in any setting (context). The design characteristics, psychosocial factors, measures, details of interventions, and outcomes of included studies were described in detail. Twenty-one studies were identified, including sixteen cross-sectional studies and five interventional studies. Ten categories of psychosocial factors that are associated with QoL in acromegaly. Depression and anxiety were the most frequent psychosocial factors. Seven different validated QoL measures were used. AcroQoL was the most common measure. Two categories of complementary interventions targeting QoL were identified including psychological and exercise interventions. Our scoping review provides a reasonably clear picture of the current research status of QoL in acromegaly. However, this review also highlights the need to deepen understanding of QoL and psychosocial factors in the future, as well as conduct longitudinal research and qualitative research to clarify the changing trends of psychosocial factors and specific experiences of patients. Further, more potential clinical complementary interventions are needed to improve QoL for patients with acromegaly.
Identifiants
pubmed: 38965637
doi: 10.1186/s13023-024-03246-2
pii: 10.1186/s13023-024-03246-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
251Informations de copyright
© 2024. The Author(s).
Références
Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R. Acromegaly. Nature reviews. Disease Primers. 2019;5(1):20.
pubmed: 30899019
doi: 10.1038/s41572-019-0071-6
Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N. Epidemiology of acromegaly: review of population studies. Pituitary. 2017;20(1):4–9.
pubmed: 27743174
doi: 10.1007/s11102-016-0754-x
Gadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic complications of Acromegaly and the impact of the Current Treatment Landscape: an update. Endocr Rev. 2019;40(1):268–332.
pubmed: 30184064
doi: 10.1210/er.2018-00115
Giustina A, Barkan A, Beckers A, Biermasz N, Biller BMK, Boguszewski C, Bolanowski M, Bonert V, Bronstein MD, Casanueva FF, Clemmons D, Colao A, Ferone D, Fleseriu M, Frara S, Gadelha MR, Ghigo E, Gurnell M, Heaney AP, Ho K, Melmed S. A Consensus on the diagnosis and treatment of Acromegaly comorbidities: an update. J Clin Endocrinol Metab. 2020;105(4):dgz096.
pubmed: 31606735
doi: 10.1210/clinem/dgz096
Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA. & Endocrine Society (2014). Acromegaly: an endocrine society clinical practice guideline. The Journal of clinical endocrinology and metabolism, 99(11), 3933–3951.
Wolters TLC, Roerink SHPP, Sterenborg RBTM, Wagenmakers MAEM, Husson O, Smit JWA, Hermus AR, M. M., Netea-Maier RT. The effect of treatment on quality of life in patients with acromegaly: a prospective study. Eur J Endocrinol. 2020;182(3):319–31.
pubmed: 31958318
doi: 10.1530/EJE-19-0732
Kyriakakis N, Lynch J, Gilbey SG, Webb SM, Murray RD. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: results from a 5-years prospective study. Clin Endocrinol. 2017;86(6):806–15.
doi: 10.1111/cen.13331
Sibeoni J, Manolios E, Verneuil L, Chanson P, Revah-Levy A. Patients’ perspectives on acromegaly diagnostic delay: a qualitative study. Eur J Endocrinol. 2019;180(6):339–52.
pubmed: 30939451
doi: 10.1530/EJE-18-0925
Liu S, Adelman DT, Xu Y, Sisco J, Begelman SM, Webb SM, Badia X, Thethi TK, Fonseca V, Shi L. Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly. J Invest Medicine: Official Publication Am Federation Clin Res. 2018;66(3):653–60.
doi: 10.1136/jim-2017-000570
WHO Quality of Life Assessment Group. What quality of life? Geneva, Switzerland: World Health Forum; 1996.
Guilbert JJ. The world health report 2. Educ Health (Abingdon). 2003;16(2):230.
pubmed: 14741909
Shimatsu A, Nagashima M, Hashigaki S, Ohki N, Chihara K. Efficacy and safety of monotherapy by pegvisomant, a growth hormone receptor antagonist, in Japanese patients with acromegaly. Endocr J. 2016;63(4):337–47.
pubmed: 26796763
doi: 10.1507/endocrj.EJ15-0619
Fujio S, Arimura H, Hirano H, Habu M, Bohara M, Moinuddin FM, Kinoshita Y, Arita K. Changes in quality of life in patients with acromegaly after surgical remission - A prospective study using SF-36 questionnaire. Endocr J. 2017;64(1):27–38.
pubmed: 27681883
doi: 10.1507/endocrj.EJ16-0182
van der Klaauw AA, Biermasz NR, Hoftijzer HC, Pereira AM, Romijn JA. Previous radiotherapy negatively influences quality of life during 4 years of follow-up in patients cured from acromegaly. Clin Endocrinol. 2008;69(1):123–8.
doi: 10.1111/j.1365-2265.2007.03169.x
Singh-Manoux A. Psychosocial factors and public health. J Epidemiol Commun Health. 2003;57(8):553–5.
doi: 10.1136/jech.57.8.553
Moon S, Hong S, Han K, Park CY. Risk of depression in patients with acromegaly in Korea (2006–2016): a nationwide population-based study. Eur J Endocrinol. 2023;189(3):363–71.
pubmed: 37647116
doi: 10.1093/ejendo/lvad120
Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK. Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol. 2009;71(5):691–701.
doi: 10.1111/j.1365-2265.2009.03555.x
Geraedts VJ, Dimopoulou C, Auer M, Schopohl J, Stalla GK, Sievers C. Health outcomes in Acromegaly: depression and anxiety are promising targets for improving reduced quality of life. Front Endocrinol. 2015;5:229.
doi: 10.3389/fendo.2014.00229
Vermalle M, Alessandrini M, Graillon T, Paladino NC, Baumstarck K, Sebag F, Dufour H, Brue T, Castinetti F. Lack of functional remission in Cushing’s syndrome. Endocrine. 2018;61(3):518–25.
pubmed: 30019306
doi: 10.1007/s12020-018-1664-7
Geraedts VJ, Andela CD, Stalla GK, Pereira AM, van Furth WR, Sievers C, Biermasz NR. Predictors of quality of life in Acromegaly: no Consensus on biochemical parameters. Front Endocrinol. 2017;8:40.
doi: 10.3389/fendo.2017.00040
Broersen LHA, Zamanipoor Najafabadi AH, Pereira AM, Dekkers OM, van Furth WR, Biermasz NR. Improvement in symptoms and Health-Related Quality of Life in Acromegaly patients: a systematic review and Meta-analysis. J Clin Endocrinol Metab. 2021;106(2):577–87.
pubmed: 33245343
doi: 10.1210/clinem/dgaa868
Arksey H, OMalley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.
doi: 10.1080/1364557032000119616
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Straus SE. PRISMA Extension for scoping reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018;169(7):467–73.
pubmed: 30178033
doi: 10.7326/M18-0850
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, McInerney P, Godfrey CM, Khalil H. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Implement. 2021;19(1):3–10.
pubmed: 33570328
doi: 10.1097/XEB.0000000000000277
Cangiano, B., Giusti, E., Premoli, C., Soranna, D., Vitale, G., Grottoli, S., Cambria,V., Mantovani, G., Mungari, R., Maffei, P., Dassie, F., Giampietro, A., Chiloiro,S., Tanda, M. L., Ippolito, S., Cannavò, S., Ragonese, M., Zambon, A., Persani, L.,Fatti, L. M., … PRO-ACRO study group on Motor Disability in Acromegaly, of the Italian Society of Endocrinology (SIE) (2022). Psychological complications in patients with acromegaly: relationships with sex, arthropathy, and quality of life. Endocrine, 77(3), 510–518.
Kepicoglu H, Hatipoglu E, Bulut I, Darici E, Hizli N, Kadioglu P. Impact of treatment satisfaction on quality of life of patients with acromegaly. Pituitary. 2014;17(6):557–63.
pubmed: 24337714
doi: 10.1007/s11102-013-0544-7
Celik O, Kadioglu P. Quality of life in female patients with acromegaly. J Endocrinol Investig. 2013;36(6):412–6.
Pivonello R, Auriemma RS, Veneri D, Dassie A, Lorusso F, Ragonese R, Liotta M, Sala M, Zarino E, Lai B, Urbani E, Bogazzi C, Mantovani F, Cannavò G, Maffei S, Chiodini P, P., Colao A. Global psychological assessment with the evaluation of life and sleep quality and sexual and cognitive function in a large number of patients with acromegaly: a cross-sectional study. Eur J Endocrinol. 2022;187(6):823–45.
pubmed: 36165745
pmcid: 9782455
doi: 10.1530/EJE-22-0263
Ballesteros-Herrera D, Briseño-Hernández P, Pérez-Esparza R, Portocarrero-Ortiz LA. (2021). Differences in quality of life between genders in acromegaly. Endocrinol Diabetes Metabolism, 4(2), e00229.
Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab. 2004;89(11):5369–76.
pubmed: 15531483
doi: 10.1210/jc.2004-0669
Jawiarczyk-Przybyłowska A, Szcześniak D, Ciułkowicz M, Bolanowski M, Rymaszewska J. Importance of Illness Acceptance among other factors affecting quality of life in Acromegaly. Front Endocrinol. 2020;10:899.
doi: 10.3389/fendo.2019.00899
Anagnostis P, Efstathiadou ZA, Charizopoulou M, Selalmatzidou D, Karathanasi E, Poulasouchidou M, Kita M. Psychological profile and quality of life in patients with acromegaly in Greece. Is there any difference with other chronic diseases? Endocrine. 2014;47(2):564–71.
pubmed: 24510628
doi: 10.1007/s12020-014-0166-5
Zhang X, Li Y, Zhong Y, Wang Z. Variables Associated with body image concerns in Acromegaly patients: a cross-sectional study. Front Psychol. 2022;13:733864.
pubmed: 35756208
pmcid: 9226896
doi: 10.3389/fpsyg.2022.733864
Roerink SH, Wagenmakers MA, Wessels JF, Sterenborg RB, Smit JW, Hermus AR, Netea-Maier RT. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly. Pituitary. 2015;18(3):366–75.
pubmed: 24965695
doi: 10.1007/s11102-014-0583-8
Tiemensma J, Kaptein AA, Pereira AM, Smit JW, Romijn JA, Biermasz NR. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly. J Clin Endocrinol Metab. 2011;96(11):3550–8.
pubmed: 21917873
doi: 10.1210/jc.2011-1645
T’Sjoen G, Bex M, Maiter D, Velkeniers B, Abs R. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly. Eur J Endocrinol. 2007;157(4):411–7.
pubmed: 17893254
doi: 10.1530/EJE-07-0356
Li Y, Zhang X, Zhang J, Zhang D, Wang Y, Zhu Y, Xu X. Stigma and unhealthy psychological characteristics in patients with acromegaly: a cross-sectional study and identification of the associated factors. Acta Neurochir. 2022;164(8):2069–81.
pubmed: 35597876
doi: 10.1007/s00701-022-05246-2
Andela CD, Biermasz NR, Kaptein AA, Pereira AM, Tiemensma J. More concerns and stronger beliefs about the necessity of medication in patients with acromegaly are associated with negative illness perceptions and impairment in quality of life. Growth hormone & IGF research. Official J Growth Hormone Res Soc Int IGF Res Soc. 2015;25(5):219–26.
doi: 10.1016/j.ghir.2015.06.008
Wennberg A, Lorusso R, Dassie F, Benavides-Varela S, Parolin M, De Carlo E, Fallo F, Mioni R, Vettor R, Semenza C, Maffei P. Sleep disorders and cognitive dysfunction in acromegaly. Endocrine. 2019;66(3):634–41.
pubmed: 31473920
doi: 10.1007/s12020-019-02061-1
Santos A, Nalin C, Bortolotti G, Dominguez-Clave E, Daniela G, Cortesi L, Pagani M, Momblan MAM, Gich I, Webb SM, Trevisan R, Resmini E. The effect of mindfulness therapy in acromegaly, a pilot study. Clin Endocrinol. 2023;98(3):363–74.
doi: 10.1111/cen.14844
Halilolu Z, Szer S, Korkmaz ZP, Ahin S, Durcan E, Oral G et al. (2020). The effects of psychological focus group therapy on the quality of life of female patients with acromegaly. Turkish J Endocrinol Metabolism(4).
Kunzler LS, Naves LA, Casulari LA. Cognitive-behavioral therapy improves the quality of life of patients with acromegaly. Pituitary. 2018;21(3):323–33.
pubmed: 29644512
doi: 10.1007/s11102-018-0887-1
Lima TRL, Kasuki L, Gadelha M, Lopes AJ. Physical exercise improves functional capacity and quality of life in patients with acromegaly: a 12-week follow-up study. Endocrine. 2019;66(2):301–9.
pubmed: 31317523
doi: 10.1007/s12020-019-02011-x
Hatipoglu E, Topsakal N, Atilgan OE, Alcalar N, Camliguney AF, Niyazoglu M, Cotuk HB, Kadioglu P. Impact of exercise on quality of life and body-self perception of patients with acromegaly. Pituitary. 2014;17(1):38–43.
pubmed: 23377883
doi: 10.1007/s11102-013-0463-7
The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. (1995). Social science & medicine (1982), 41(10), 1403–1409.
Coopmans EC, Andela CD, Claessen KMJA, Biermasz NR. Evaluating the impact of Acromegaly on Quality of Life. Endocrinol Metab Clin North Am. 2022;51(4):709–25.
pubmed: 36244688
doi: 10.1016/j.ecl.2022.04.004
Webb SM, Badia X. Quality of life in Acromegaly. Neuroendocrinology. 2016;103(1):106–11.
pubmed: 25661974
doi: 10.1159/000375451
Matta MP, Couture E, Cazals L, Vezzosi D, Bennet A, Caron P. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance. Eur J Endocrinol. 2008;158(3):305–10.
pubmed: 18299462
doi: 10.1530/EJE-07-0697
Solomon E, Brănișteanu D, Dumbravă A, Solomon RG, Kiss L, Glod M, Preda C. Executive functioning and quality of life in acromegaly. Psychol Res Behav Manage. 2019;12:39–44.
doi: 10.2147/PRBM.S183950
Kunzler LS, Naves LA, Casulari LA. The effect of cognitive-behavioral therapy on Acromegalics after a 9-Month Follow-Up. Front Endocrinol. 2019;10:380.
doi: 10.3389/fendo.2019.00380
Dimopoulou C, Leistner SM, Ising M, Schneider HJ, Schopohl J, Rutz S, Kosilek R, Frohner R, Stalla GK, Sievers C. Body image perception in acromegaly is not Associated with Objective Acromegalic Changes but depends on depressive symptoms. Neuroendocrinology. 2017;105(2):115–22.
pubmed: 27453978
doi: 10.1159/000448519
Yamamoto N, Urai S, Fukuoka H, Yamamoto M, Yoshida K, Suzuki M, Shichi H, Fujita Y, Kanie K, Iguchi G, Takahashi Y, Ogawa W. The Effect of Aging on Quality of Life in Acromegaly patients under treatment. Front Endocrinol. 2022;13:819330.
doi: 10.3389/fendo.2022.819330
Fatti LM, Cangiano B, Vitale G, Persani L, Mantovani G, Sala E, Arosio M, Maffei P, Dassie F, Mormando M, Giampietro A, Tanda L, Masiello ER, Nazzari E, Ferone D, Corbetta S, Passeri E, Guaraldi F, Grottoli S, Cannavò S, Study Group on Motor Disability in Acromegaly of the Italian Society of Endocrinology. Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity. Pituitary. 2019;22(5):552–60.
pubmed: 31032537
doi: 10.1007/s11102-019-00966-8
Tseng FY, Chen ST, Chen JF, Huang TS, Lin JD, Wang PW, Huey-Herng Sheu W, Chang TC, Acromegaly Registry Study Group. Correlations of clinical parameters with quality of life in patients with acromegaly: Taiwan Acromegaly Registry. J Formos Med Association = Taiwan Yi Zhi. 2019;118(11):1488–93.
pubmed: 31147197
doi: 10.1016/j.jfma.2019.05.007
Webb SM, Badia X, Surinach NL, Spanish AcroQol Study Group. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study. Eur J Endocrinol. 2006;155(2):269–77.
pubmed: 16868140
doi: 10.1530/eje.1.02214
Mokkink LB, de Vet HCW, Prinsen CAC, Patrick DL, Alonso J, Bouter LM, Terwee CB. COSMIN Risk of Bias checklist for systematic reviews of patient-reported outcome measures. Qual life Research: Int J Qual life Aspects Treat care Rehabilitation. 2018;27(5):1171–9.
doi: 10.1007/s11136-017-1765-4